These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

115 related articles for article (PubMed ID: 29966597)

  • 1. Titration of cell-associated varicella-zoster virus with the MV9G reporter cell line for antiviral studies.
    Li X; Li X; Gong W; Wang G; Lu Z; Wu N; Lian C; Huang L; Inoue N
    J Virol Methods; 2018 Oct; 260():14-20. PubMed ID: 29966597
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Generation of a reporter cell line for detection of infectious varicella-zoster virus and its application to antiviral studies.
    Wang GQ; Suzutani T; Yamamoto Y; Fukui Y; Nozawa N; Schmid DS; Kurane I; Inoue N
    Antimicrob Agents Chemother; 2006 Sep; 50(9):3142-5. PubMed ID: 16940113
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Antiviral activity of propolis special extract GH 2002 against
    Labská K; Plodková H; Pumannová M; Sensch KH
    Pharmazie; 2018 Dec; 73(12):733-736. PubMed ID: 30522559
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Antiviral bioactivity of renewable polysaccharides against
    Abu-Galiyun E; Huleihel M; Levy-Ontman O
    Cell Cycle; 2019 Dec; 18(24):3540-3549. PubMed ID: 31724465
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Inhibition of DNA synthesis in varicella-zoster virus-infected cells by BV-araU.
    Machida H; Watanabe Y
    Microbiol Immunol; 1991; 35(2):139-45. PubMed ID: 1653394
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Emergence of resistance to acyclovir and penciclovir in varicella-zoster virus and genetic analysis of acyclovir-resistant variants.
    Ida M; Kageyama S; Sato H; Kamiyama T; Yamamura J; Kurokawa M; Morohashi M; Shiraki K
    Antiviral Res; 1999 Jan; 40(3):155-66. PubMed ID: 10027650
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Characterization of an anti-varicella-zoster virus compound that targets the portal protein encoded by ORF54.
    Yasui R; Yoshida C; Yamaguchi T; Inoue N
    Microbiol Immunol; 2017 Sep; 61(9):398-402. PubMed ID: 28833387
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Honeysuckle-derived microRNA2911 directly inhibits varicella-zoster virus replication by targeting IE62 gene.
    Huang Y; Liu H; Sun X; Ding M; Tao G; Li X
    J Neurovirol; 2019 Aug; 25(4):457-463. PubMed ID: 31140131
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Genetic polymorphism of thymidine kinase (TK) and DNA polymerase (pol) of clinical varicella-zoster virus (VZV) isolates collected over three decades.
    Hoffmann A; Döring K; Seeger NT; Bühler M; Schacke M; Krumbholz A; Sauerbrei A
    J Clin Virol; 2017 Oct; 95():61-65. PubMed ID: 28886462
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Characterization of a thienylcarboxamide derivative that inhibits the transactivation functions of cytomegalovirus IE2 and varicella zoster virus IE62.
    Majima R; Shindoh K; Yamaguchi T; Inoue N
    Antiviral Res; 2017 Apr; 140():142-150. PubMed ID: 28161581
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Antiviral drugs for varicella-zoster virus and herpes simplex virus infections.
    Med Lett Drugs Ther; 2018 Sep; 60(1556):153-157. PubMed ID: 30383727
    [No Abstract]   [Full Text] [Related]  

  • 12. Selection and characterization of varicella-zoster virus variants resistant to (R)-9-[4-hydroxy-2-(hydroxymethy)butyl]guanine.
    Ng TI; Shi Y; Huffaker HJ; Kati W; Liu Y; Chen CM; Lin Z; Maring C; Kohlbrenner WE; Molla A
    Antimicrob Agents Chemother; 2001 Jun; 45(6):1629-36. PubMed ID: 11353604
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Development of Robust Varicella Zoster Virus Luciferase Reporter Viruses for In Vivo Monitoring of Virus Growth and Its Antiviral Inhibition in Culture, Skin, and Humanized Mice.
    Lloyd MG; Yee MB; Flot JS; Liu D; Geiler BW; Kinchington PR; Moffat JF
    Viruses; 2022 Apr; 14(4):. PubMed ID: 35458556
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Evaluation of varicella-zoster antiviral drugs by a nucleic acid hybridization assay.
    Stanberry LR; Myers MG
    Antiviral Res; 1988 Sep; 9(6):367-77. PubMed ID: 2852488
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Comparative efficacy of acyclovir and vidarabine on the replication of varicella-zoster virus.
    Miwa N; Kurosaki K; Yoshida Y; Kurokawa M; Saito S; Shiraki K
    Antiviral Res; 2005 Jan; 65(1):49-55. PubMed ID: 15652971
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Comparison of antiviral assay methods using cell-free and cell-associated varicella-zoster virus.
    Shiraki K; Ochiai H; Namazue J; Okuno T; Ogino S; Hayashi K; Yamanishi K; Takahashi M
    Antiviral Res; 1992 Jun; 18(2):209-14. PubMed ID: 1329651
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Antiviral activity of liquorice powder extract against varicella zoster virus isolated from Egyptian patients.
    Shebl RI; Amin MA; Emad-Eldin A; Bin Dajem SM; Mostafa AS; Ibrahim EH; Mohamed AF
    Chang Gung Med J; 2012; 35(3):231-9. PubMed ID: 22735054
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Resistance testing of clinical varicella-zoster virus strains.
    Sauerbrei A; Taut J; Zell R; Wutzler P
    Antiviral Res; 2011 Jun; 90(3):242-7. PubMed ID: 21539861
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Susceptibilities of several clinical varicella-zoster virus (VZV) isolates and drug-resistant VZV strains to bicyclic furano pyrimidine nucleosides.
    Andrei G; Sienaert R; McGuigan C; De Clercq E; Balzarini J; Snoeck R
    Antimicrob Agents Chemother; 2005 Mar; 49(3):1081-6. PubMed ID: 15728906
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Antiviral resistance of herpes simplex virus and varicella-zoster virus].
    Daikoku T; Shiraki K
    Nihon Rinsho; 2007 Feb; 65 Suppl 2 Pt. 1():480-6. PubMed ID: 17455667
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 6.